Details of recurrence sites after definitive radiation therapy for cervical cancer.
- Author:
Reiko KOBAYASHI
1
;
Hideomi YAMASHITA
;
Kae OKUMA
;
Kuni OHTOMO
;
Keiichi NAKAGAWA
Author Information
- Publication Type:Original Article
- Keywords: Radiation Therapy; Recurrence; Uterine Cervical Neoplasms
- MeSH: Adenocarcinoma/drug therapy/*radiotherapy/secondary; Adult; Aged; Aged, 80 and over; Antineoplastic Agents/therapeutic use; Brachytherapy; Carcinoma, Squamous Cell/drug therapy/*radiotherapy/secondary; Chemoradiotherapy; Disease-Free Survival; Dose Fractionation; Female; Follow-Up Studies; Humans; Lung Neoplasms/*secondary; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local/*diagnosis; Pelvis; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms/drug therapy/pathology/*radiotherapy
- From:Journal of Gynecologic Oncology 2016;27(2):e16-
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVE: This is a retrospective study aimed at clarifying the details of recurrence patterns and sites in patients with cervical cancer treated with definitive radiation therapy (RT). METHODS: Data were analyzed from consecutive patients, admitted to the University of Tokyo Hospital (Tokyo, Japan) between 2001 and 2013, who had received definitive RT, with or without chemotherapy, for International Federation of Gynecology and Obstetrics stages IB-IVA cervical cancer. RESULTS: One hundred and thirty-seven patients formed the patient cohort. The median follow-up period for surviving patients was 57.0 months. A complete response was achieved in 121 patients (88%). Of these, 36 (30%) developed a cancer recurrence during follow-up. The first sites of recurrence were located in intra-RT fields in nine, outside RT fields in 20, and both in seven patients. In the intra-RT field group, all patients showed a local recurrence, while no one experienced an isolated pelvic lymph node (PLN) recurrence. In the outside RT field group, the most frequent site of recurrence was lung (60%), and three-quarters of patients were free from intra-RT field recurrence until the last follow-up. Of the entire cohort, including 48 PLN-positive patients, only seven patients (5.1%) developed PLN persistence or recurrence, all in the common iliac, internal iliac, and/or obturator nodes, and all with another synchronous relapse. CONCLUSION: Local disease was a major type of intra-RT field recurrence, while PLN control was favorable even in initially PLN-positive patients. The predominance of outside RT field recurrence alone highlights issues concerning distant control, including the intensity enhancement of systematic therapy.
